Congenital chylothorax: A series of eight cases
Keywords:chylothorax, congenital abnormality, hydrops fetalis, neonatal, octreotide, pleural effusion
Introduction: Congenital chylothorax (CC) is the accumulation of lymph in the pleural space. The aim of this study was to review the cases of CC diagnosed in newborns admitted to a level III neonatal intensive care unit between January 2014 and December 2020.
Results: Eight cases of CC were identified, all with prenatal diagnosis. After postnatal confirmation of the diagnosis, supportive care and conservative therapy were initiated. Six cases underwent mechanical ventilation, two were treated with surfactant and inhaled nitric oxide, four required inotropic support, and one underwent extracorporeal membrane oxygenation. Five newborns were effectively treated with octreotide. One patient with hydrops fetalis died after birth.
Discussion: The prognosis of CC depends on the severity of the effusion and on associated abnormalities. Medical treatment is based on supportive and conservative treatment. Although the use of octreotide is not unanimous, it proved to be an effective and safe adjuvant therapy in these patients.
Sahoo T, Mangla MK, Sethi A, Thukral A. Successful treatment of congenital chylothorax with skimmed milk and long course octreotide. BMJ Case Rep. 2018; 11: e22634. https://doi.org/10.1136/bcr-2018-226347.
De Angelis LC, Bellini T, Witte MH, Kylat RI, Bernas M, Boccardo F, et al. Congenital chylothorax: Current evidence-based prenatal and post-natal diagnosis and management. Lymphology. 2019; 52(3): 108-25. https://doi.org/10.2458/lymph.4632.
Dorsi M, Giuseppi A, Lesage F, Stirmann J, De Saint Blanquat L, Nicloux M, et al. Prenatal factors associated with neonatal survival of infants with congenital chylothorax. J Perinatol. 2018; 38(1): 31-34. https://doi.org/10.1038/jp.2017.150.
Brock W, Bradshaw W. Congenital Chylothorax: a unique presentation of nonimmune hydrops fetalis in a preterm infant. Advances in Neonatal Care. 2016; 16(2): 114-23. https://doi.org/10.1097/ANC.0000000000000257.
Fonseca J, Gonçalves M. Quilotórax Neonatal: Série de Sete Casos Clínicos. Acta Pediatr Port. 2017; 48: 147-52. https://doi.org/10.25754/pjp.2017.10273.
Tutor J. Chylothorax in Infants and Children. Pediatrics. 2014; 133(4): 722-33. https://doi.org/10.1542/peds.2013-2072
Attar MA, Donn SM. Congenital chylothorax. Semin Fetal Neonatal Med. 2017; 22(4): 234-9. https://doi.org/10.1016/j.siny.2017.03.005.
Bellini C, Cabano R, De Angelis LC, Bellini T, Calevo MG, Gandullia P, et al. Octreotide for congenital and acquired chylothorax in newborns: A systematic review. J Paediatr Child Health. 2018; 54(8): 840-47. https://doi.org/10.1111/jpc.13889.
Barreira R, Marques MI, Valsassina R, Cardoso K, Salazar A. Chylothorax in a Level III Neonatal Intensive Care Unit: A Case Series. Gaz Med. 2018; 5(2): 151-55.
Vass G, Evans Fry R, Roehr C. Should Newborns with Refractory Chylothorax Be Tried on Higher Dose of Octreotide? Neonatology 2021; 118: 122-6. https://doi.org/10.1159/000512461.
Kobeisy SAN, Alkhotani A, Barzanji MM. Octreotide Infusion for the Treatment of Congenital Chylothorax. Case Rep Pediatr. 2020:8890860. https://doi.org/10.1155/2020/8890860.
Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;(9):CD006388. https://doi.org/10.1002/14651858.CD006388.pub2.
Downie L, Sasi A, Malhotra A. Congenital chylothorax: associations and neonatal outcomes. J Paediatr Child Health. 2014; 50: 234– 38. https://doi.org/10.1111/jpc.12477.
Bialkowski A, Poets FC, Franz AR. Congenital chylothorax: a prospective nationwide epidemiological study in Germany. Arch Dis Child Fetal Neonatal Ed. 2015; 100: F169-F172. https://doi.org/10.1136/archdischild-2014-307274.
Shah D, Sinn JK. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series. Acta Paediatr. 2012; 101(4): e151-5. https://doi.org/10.1111/j.1651-2227.2011.02529.x.
How to Cite
Copyright (c) 2023 Joana Jorge Antunes, Madalena Borges, Andreia Mascarenhas, Sara Brito, Célia Iglesias, Eduardo Fernandes, Eunice Vieira, Filomena Pinto, Leonor Ferreira, Teresa Tomé, José Nona
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.